Patents by Inventor Mark Walden

Mark Walden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220341202
    Abstract: Pumping and water distribution systems for pools/spas, and methods for control thereof are provided. A system includes a pump including a variable speed motor, a controller configured to control the speed of the motor, a plurality of pool/spa components, a plumbing subsystem placing the components in fluidic communication with the pump, and a plurality of control valves switchable between an open position and a closed position. Each of the control valves is associated with one of the components, positioned in the plumbing subsystem between the associated component and the pump to control the flow of fluid to the associated component, and is configured to provide a specific flow rate of fluid to the associated component based on a set system pressure when in the open position. The controller adjusts the speed of the motor to adjust the fluid pressure within the plumbing subsystem to match the set system pressure value.
    Type: Application
    Filed: September 11, 2020
    Publication date: October 27, 2022
    Applicant: Hayward Industries, Inc.
    Inventors: Steven James Goettl, Dominic Conn, John M. Goettl, Mark Walden
  • Patent number: 11400104
    Abstract: Disclosed herein are methods and compositions for removing or displacing bisphosphonates in skeletal tissue.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: August 2, 2022
    Assignees: The Regents of the University of California, BioVinc LLC, University of Southern California
    Inventors: Frank Hallock Ebetino, Ichiro Nishimura, Shuting Sun, Mark Walden Lundy, Akishige Hokugo, Charles McKenna, Keivan Sadrerafi
  • Publication number: 20210121485
    Abstract: Disclosed herein are methods and compositions for removing or displacing bisphosphonates in skeletal tissue.
    Type: Application
    Filed: October 29, 2020
    Publication date: April 29, 2021
    Inventors: Frank Hallock Ebetino, Ichiro Nishimura, Shuting Sun, Mark Walden Lundy, Akishige Hokugo, Charles McKenna, Keivan Sadrerafi
  • Patent number: 10857165
    Abstract: Disclosed herein are methods and compositions for removing or displacing bisphosphonates in skeletal tissue.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: December 8, 2020
    Assignees: The Regents of the University of California, BioVinc LLC, University of Southern California
    Inventors: Frank Hallock Ebetino, Ichiro Nishimura, Shuting Sun, Mark Walden Lundy, Akishige Hokugo, Charles McKenna, Keivan Sadrerafi
  • Publication number: 20190209590
    Abstract: Disclosed herein are methods and compositions for removing or displacing bisphosphonates in skeletal tissue.
    Type: Application
    Filed: May 31, 2017
    Publication date: July 11, 2019
    Inventors: Frank Hallock Ebetino, Ph.D., Ichiro Nishimura, Shuting Sun, Mark Walden Lundy, Akishige Hokugo, Charles McKenna, Keivan Sadrerafi
  • Publication number: 20140056174
    Abstract: Implementations are disclosed that provide protocols for connecting an intelligent service module within a storage area network (SAN). The protocols support physical connections between the intelligent service module and a director-level switch of the SAN. In some variations, the intelligent service module may comprise a director service module (DSM), a domain-sharing leaf switch service module (LSSM), or a non-domain-sharing LSSM. The protocols provide for establishing link parameters and negotiating responsibilities between the intelligent service module and the director-level switch. In one configuration, for example, ELP and ELP_ACCEPT frames may be used to establish the link parameters. In another configuration, ESC and ESC_ACCEPT frames may be used to negotiate responsibilities between the intelligent service module and the director-level switch.
    Type: Application
    Filed: October 25, 2013
    Publication date: February 27, 2014
    Applicant: BROCADE COMMUNICATIONS SYSTEMS, INC.
    Inventors: James Mark Walden, Keith J. Noe, Jesse B. Willeke
  • Patent number: 8618079
    Abstract: Novel imidazo[1,2-?]pyridinyl bisphosphonate compounds are disclosed, as well as methods of preparing the compounds, pharmaceutical compositions including the compounds, and administration of the compounds in methods of treating abnormal calcium and phosphate metabolism, including bone and joint diseases and other disorders.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: December 31, 2013
    Assignee: Isis Innovation Limited
    Inventors: Frank Hallock Ebetino, Adam Mazur, Mark Walden Lundy, Robert Graham Russell
  • Patent number: 8595352
    Abstract: Implementations are disclosed that provide protocols for connecting an intelligent service module within a storage area network (SAN). The protocols support physical connections between the intelligent service module and a director-level switch of the SAN. In some variations, the intelligent service module may comprise a director service module (DSM), a domain-sharing leaf switch service module (LSSM), or a non-domain-sharing LSSM. The protocols provide for establishing link parameters and negotiating responsibilities between the intelligent service module and the director-level switch. In one configuration, for example, ELP and ELP_ACCEPT frames may be used to establish the link parameters. In another configuration, ESC and ESC_ACCEPT frames may be used to negotiate responsibilities between the intelligent service module and the director-level switch.
    Type: Grant
    Filed: April 29, 2011
    Date of Patent: November 26, 2013
    Assignee: Brocade Communications Systems, Inc.
    Inventors: James Mark Walden, Keith J. Noe, Jesse B. Willeke
  • Patent number: 8252774
    Abstract: Novel 5-azaindole bisphosphonate compounds are disclosed, as well as methods of preparing the compounds, pharmaceutical compositions including the compounds, and administration of the compounds in methods of treating abnormal calcium and phosphate metabolism, including bone and joint diseases and other disorders.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: August 28, 2012
    Assignee: Isis Innovation Ltd.
    Inventors: Frank Hallock Ebetino, Adam Mazur, Mark Walden Lundy, Robert Graham Russell
  • Publication number: 20120106393
    Abstract: Implementations are disclosed that provide protocols for connecting an intelligent service module within a storage area network (SAN). The protocols support physical connections between the intelligent service module and a director-level switch of the SAN. In some variations, the intelligent service module may comprise a director service module (DSM), a domain-sharing leaf switch service module (LSSM), or a non-domain-sharing LSSM. The protocols provide for establishing link parameters and negotiating responsibilities between the intelligent service module and the director-level switch. In one configuration, for example, ELP and ELP_ACCEPT frames may be used to establish the link parameters. In another configuration, ESC and ESC_ACCEPT frames may be used to negotiate responsibilities between the intelligent service module and the director-level switch.
    Type: Application
    Filed: April 29, 2011
    Publication date: May 3, 2012
    Applicant: McDATA CORPORATION
    Inventors: James Mark Walden, Keith Noe, Jesse Willeke
  • Publication number: 20110237550
    Abstract: Novel 5-azaindole bisphosphonate compounds are disclosed, as well as methods of preparing the compounds, pharmaceutical compositions including the compounds, and administration of the compounds in methods of treating abnormal calcium and phosphate metabolism, including bone and joint diseases and other disorders.
    Type: Application
    Filed: September 22, 2009
    Publication date: September 29, 2011
    Applicant: ISIS INNOVATION LTD.
    Inventors: Frank Hallock Ebetino, Adam Mazur, Mark Walden Lundy, Robert Graham Russell
  • Publication number: 20110230443
    Abstract: Novel imidazo[1,2-?]pyridinyl bisphosphonate compounds are disclosed, as well as methods of preparing the compounds, pharmaceutical compositions including the compounds, and administration of the compounds in methods of treating abnormal calcium and phosphate metabolism, including bone and joint diseases and other disorders.
    Type: Application
    Filed: September 22, 2009
    Publication date: September 22, 2011
    Applicant: ISIS INNOVATION LTD.
    Inventors: Frank Hallock Ebetino, Adam Mazur, Mark Walden Lundy, Robert Graham Russell
  • Patent number: 7953866
    Abstract: Implementations are disclosed that provide protocols for connecting an intelligent service module within a storage area network (SAN). The protocols support physical connections between the intelligent service module and a director-level switch of the SAN. In some variations, the intelligent service module may comprise a director service module (DSM), a domain-sharing leaf switch service module (LSSM), or a non-domain-sharing LSSM. The protocols provide for establishing link parameters and negotiating responsibilities between the intelligent service module and the director-level switch. In one configuration, for example, ELP and ELP_ACCEPT frames may be used to establish the link parameters. In another configuration, ESC and ESC_ACCEPT frames may be used to negotiate responsibilities between the intelligent service module and the director-level switch.
    Type: Grant
    Filed: March 22, 2006
    Date of Patent: May 31, 2011
    Assignee: MCDATA Corporation
    Inventors: James Mark Walden, Keith J. Noe, Jesse B. Willeke
  • Patent number: 6156799
    Abstract: The present invention relates to novel methods of increasing bone volume comprising the administration of a non-naturally-occurring selective FP agonist to a subject in need of such treatment. This invention further relates to a method of treating or preventing bone disorders comprising the administration of a non-naturally-occurring selective FP agonist to a subject in need of such treatment.
    Type: Grant
    Filed: September 4, 1998
    Date of Patent: December 5, 2000
    Assignee: The Procter & Gamble Company
    Inventors: James Richard Hartke, Mark Walden Lundy, Mitchell Anthony deLong